Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01315951 · ClinicalTrials.gov registry record · NA
Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation
A NA study, sponsored by Ascension Health.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01315951 is a NA study that was terminated before completion, run by Ascension Health. The registered enrollment target is 3 participants.
The verdict
NCT01315951, a NA study, was terminated before completion, sponsored by Ascension Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The goal of this research is to demonstrate the use of petroleum jelly in prevention of nonscalp seborrheic dermatitis exacerbations at the first signs of a flare. In doing so, it will decrease the chronic use of topical steroids. The use of petrolatum should have favorable outcomes for patients, without the side-effects.
Interventions
- BIOLOGICAL Petroleum Jelly
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01315951
The ClinicalTrials.gov registry entry for NCT01315951 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ascension Health, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Petroleum Jelly is the first listed.
NCT01315951 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01315951 about?
NCT01315951 is a clinical study titled "Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation". The goal of this research is to demonstrate the use of petroleum jelly in prevention of nonscalp seborrheic dermatitis exacerbations at the first signs of a flare. In doing so, it will decrease the chronic use of topical steroids. The use of petrolatum should have favorable outcomes for patients, wi...
What is the current status of trial NCT01315951?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2011-03. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01315951?
The interventions under investigation include: Petroleum Jelly (BIOLOGICAL).
Who is sponsoring clinical trial NCT01315951?
This trial is sponsored by Ascension Health, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.